SPDR S&P Pharmaceuticals ETF (XPH): Price and Financial Metrics ETF
GET POWR RATINGS... FREE!
XPH Stock Price Chart Interactive Chart >
XPH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $39.59 | 52-week high | $52.59 |
| Prev. close | $39.81 | 52-week low | $37.94 |
| Day low | $39.50 | Volume | 27,622 |
| Day high | $40.21 | Avg. volume | 68,396 |
| 50-day MA | $42.87 | Dividend yield | 1.69% |
| 200-day MA | $43.14 |
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Pharmaceuticals Select Industry Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 209.10M |
| Net Asset Value (NAV) | $39.83 |
| Options? | Yes |
| Total Holdings | 45 |
XPH Top Holdings
| Symbol | Company | % of Total |
| SAVA | Cassava Sciences Inc | 5.6% |
| BMY | Bristol-Myers Squibb Company | 3.66% |
| JNJ | Johnson & Johnson | 3.61% |
| MRK | MERCK & CO | 3.6% |
| PRGO | Perrigo Co | 3.55% |
| LLY | ELI LILLY | 3.52% |
| PCRX | Pacira Biosciences Inc | 3.48% |
| RPRX | Repros Therapeutics Inc | 3.39% |
| PFE | Pfizer Inc | 3.35% |
| HRMY | Harmony Biosciences Holdings Inc | 3.28% |
XPH Price Returns
| 1-mo | -8.07% |
| 3-mo | -6.16% |
| 6-mo | -12.44% |
| 1-year | -16.74% |
| 3-year | 13.89% |
| 5-year | -3.34% |
| YTD | -13.24% |
| 2021 | -10.54% |
| 2020 | 14.68% |
| 2019 | 25.61% |
| 2018 | -15.32% |
| 2017 | 12.05% |
XPH Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||